UTAH MEDICAL PRODUCTS INC
Income Statement
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.5M | $8.7M | $9.0M | $9.8M | $10.0M | $9.7M | $9.2M | $10.0M |
| Cost of Revenue | $3.8M | $3.4M | $3.8M | $4.2M | $4.4M | $4.2M | $3.8M | $4.2M |
| Gross Profit | $4.8M | $5.3M | $5.3M | $5.6M | $5.6M | $5.5M | $5.3M | $5.8M |
| Gross Margin | 55.8% | 60.6% | 58.2% | 57.1% | 56.2% | 57.0% | 58.1% | 58.0% |
| Operating Expenses | ||||||||
| Research & Development | $154.0K | $154.0K | $212.0K | $167.0K | $135.0K | $154.0K | $120.0K | $172.0K |
| SG&A Expense | $2.0M | $2.6M | $559.0K | $2.8M | $2.3M | $2.2M | $371.0K | $2.3M |
| Operating Income | $2.6M | $2.6M | $2.4M | $2.6M | $3.2M | $3.2M | $2.9M | $3.3M |
| Operating Margin | 31.1% | 29.4% | 27.0% | 26.6% | 32.1% | 32.5% | 32.0% | 33.4% |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $3.3M | $3.2M | $3.1M | $3.3M | $3.8M | $3.9M | $3.6M | $4.2M |
| Income Tax Expense | $600.0K | $578.0K | $541.0K | $678.0K | $788.0K | $817.0K | $712.0K | $616.0K |
| Net Income | $2.7M | $2.6M | $2.6M | $2.6M | $3.0M | $3.0M | $2.9M | $3.6M |
| Net Margin | 31.5% | 29.9% | 28.4% | 26.8% | 30.6% | 31.3% | 31.7% | 35.6% |
| EPS (Basic) | $0.84 | $0.82 | $0.80 | $0.82 | $0.94 | $0.92 | $0.87 | $1.02 |
| EPS (Diluted) | $0.84 | $0.82 | $0.80 | $0.82 | $0.94 | $0.92 | $0.86 | $1.03 |
| Shares Outstanding (Basic) | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.3M | 3.5M | 3.5M |
| Shares Outstanding (Diluted) | 3.2M | 3.2M | 3.2M | 3.2M | 3.2M | 3.3M | 3.5M | 3.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |